Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer Ruchika Sharma25 May 2025 3:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Roche Inavolisib gets USFDA priority review for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Ruchika Sharma29 May 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application and granted Priority...
Roche gets USFDA Breakthrough Therapy Designation for Inavolisib for breast cancer with mutation Ruchika Sharma21 May 2024 2:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an...
Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market Ruchika Sharma19 Jan 2024 3:30 PM ISTAhmedabad: Zydus Lifesciences Ltd., a global healthcare company announced that its wholly owned subsidiary, Zydus Worldwide DMCC, has entered...
Pfizer, Bristol Myers, AbbVie drugs likely to face US price negotiation Ruchika Sharma14 March 2023 3:30 PM ISTNovo Nordisk's diabetes drug Ozempic, prostate cancer treatment Xtandi from Astellas Pharma and Pfizer, and J&J's blood thinner Xarelto are on three...
GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January Ruchika Sharma31 Dec 2022 1:15 PM ISTTo date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030 Ruchika Sharma13 Dec 2022 12:13 PM ISTNew York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...
Pfizer pulls Dr Reddys, Aurobindo Pharma to US court over blockbuster cancer drug Ibrance Ruchika Sharma17 Nov 2020 5:54 PM ISTPfizer in its petition stated that Aurobindo Pharma and Dr Reddys have submitted ANDA to the USFDA seeking approval to engage in commercial...
Pfizer breast cancer drug fails to meet primary endpoint Ruchika Sharma11 Oct 2020 10:15 AM ISTNeu-Isenburg & Frankfurt & New York: The German Breast Group (GBG) and Pfizer Inc. have recently announced that the collaborative...
